Literature DB >> 25911562

Loxoprofen sodium and celecoxib for postoperative pain in patients after spinal surgery: a randomized comparative study.

Hiroyuki Sekiguchi1, Gen Inoue, Toshiyuki Nakazawa, Takayuki Imura, Wataru Saito, Kentaro Uchida, Masayuki Miyagi, Naonobu Takahira, Masashi Takaso.   

Abstract

BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) are often used to treat inflammation, pain, and fever, but no criterion standard exists for the management of postoperative pain following spinal surgery. In the present study, we compared the analgesic efficacy of loxoprofen sodium (loxoprofen) and celecoxib for the management of postoperative pain following spinal surgery.
METHODS: One-hundred forty-one patients (mean age 62.2 years) were randomly assigned to two groups before spinal surgery: a loxoprofen group (n = 73, 180 mg/day) and a celecoxib group (n = 68, 200 mg/day). The drugs were administered from 1 day until 7 days after surgery. A numeric rating scale (NRS) was used to evaluate pain at nine predefined times every day and the findings were compared between the two groups. Laboratory data and adverse events were also recorded.
RESULTS: There was no significant difference in the maximum and mean NRS scores on each day between loxoprofen and celecoxib, suggesting a comparable analgesic effect for these two NSAIDs. Greater improvement in the NRS score between preadministration (baseline) and 30 min or 2 h after administration was obtained for loxoprofen. This tendency was shown for both slight (NRS score <5 at baseline) and severe pain (NRS score ≥ 5 at baseline). Loxoprofen was discontinued in one patient on day 4 because of renal dysfunction. Celecoxib was discontinued in one patient on day 2 at the patient's request.
CONCLUSIONS: Both loxoprofen sodium and celecoxib were well tolerated for the relief of acute postoperative pain after spinal surgery. A single administration of loxoprofen showed superior and rapid effectiveness compared with celecoxib for both slight and severe postoperative pain.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25911562     DOI: 10.1007/s00776-015-0726-4

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  5 in total

Review 1.  Loxoprofen: A Review in Pain and Inflammation.

Authors:  Sarah L Greig; Karly P Garnock-Jones
Journal:  Clin Drug Investig       Date:  2016-09       Impact factor: 2.859

2.  Clinical research on the efficacy and safety of Bosinji for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: A protocol for a multicenter, randomized, controlled equivalence trial.

Authors:  Bonhyuk Goo; Sung-Jin Kim; Eun-Jung Kim; Dongwoo Nam; Hyun-Jong Lee; Jae-Soo Kim; Yeon-Cheol Park; Yong-Hyeon Baek; Sang-Soo Nam; Byung-Kwan Seo
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

3.  Preemptive analgesia after lumbar spine surgery by pregabalin and celecoxib: a prospective study.

Authors:  Nguyen Trung Kien; Phillip Geiger; Hoang Van Chuong; Nguyen Manh Cuong; Ngo Van Dinh; Dinh Cong Pho; Vu The Anh; Nguyen Truong Giang
Journal:  Drug Des Devel Ther       Date:  2019-07-03       Impact factor: 4.162

4.  Exploring the Metabolism of Loxoprofen in Liver Microsomes: The Role of Cytochrome P450 and UDP-Glucuronosyltransferase in Its Biotransformation.

Authors:  Riya Shrestha; Pil Joung Cho; Sanjita Paudel; Aarajana Shrestha; Mi Jeong Kang; Tae Cheon Jeong; Eung-Seok Lee; Sangkyu Lee
Journal:  Pharmaceutics       Date:  2018-08-02       Impact factor: 6.321

5.  Assessing Drug Interaction and Pharmacokinetics of Loxoprofen in Mice Treated with CYP3A Modulators.

Authors:  Sanjita Paudel; Aarajana Shrestha; Piljoung Cho; Riya Shrestha; Younah Kim; Taeho Lee; Ju-Hyun Kim; Tae Cheon Jeong; Eung-Seok Lee; Sangkyu Lee
Journal:  Pharmaceutics       Date:  2019-09-16       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.